Increased breadth of HIV-1 neutralization achieved by diverse antibody clones each with limited neutralization breadth
CHUKWUMA, ET AL. 2018. PLOS ONE 13(12), E0209437.
RESOURCES
Where research scientists come to find up to date resources on antibody discovery against challenging membrane protein targets.
Broadly neutralizing antibody mediated clearance of human hepatitis C virus infection
KINCHEN, ET AL. 2018. CELL HOST MICROBE 24:717-730.
In vivo delivery of synthetic human DNA-encoded monoclonal antibodies protect against ebolavirus infection in a mouse model
PATEL, ET AL. 2018. CELL REPORTS 25:1982-1993.
CXCR4-targeting nanobodies differentially inhibit CXCR4 function and HIV entry
VAN HOUT, ET AL. BIOCHEM PHARMACOL 158:402-412.
Systematic analysis of monoclonal antibodies against Ebola virus GP defines features that contribute to protection
SAPHIRE, ET AL. 2018. CELL 174(4):938-952
Multifunctional pan-ebolavirus antibody recognizes a site of broad vulnerability on the ebolavirus glycoprotein
GILCHUK, ET AL. 2018. IMMUNITY 49(2):363-374.
Mxra8 is a receptor for multiple arthritogenic alphaviruses
ZHANG. 2018. NATURE 557, 570-574.
Human antibody recognition of antigenic site IV on Pneumovirus fusion proteins
MOUSA. 2018. PLOS PATHOGENS 14(2), e1006837.
Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2–MPER region
FLYAK. 2018. NATURE MICROBIOLOGY 3, 670-677.
Rush to protect lucrative antibody patents kicks into gear
LEDFORD. 2018. NATURE 557, 623-624.
